Huadong Medicine Co (SZSE:000963) Other Long-Term Liabilities : ¥459 Mil (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Huadong Medicine Co Other Long-Term Liabilities?

Huadong Medicine Co's other long-term liabilities for the quarter that ended in Mar. 2024 was ¥459 Mil.

Huadong Medicine Co's quarterly other long-term liabilities declined from Sep. 2023 (¥576 Mil) to Dec. 2023 (¥547 Mil) and declined from Dec. 2023 (¥547 Mil) to Mar. 2024 (¥459 Mil).

Huadong Medicine Co's annual other long-term liabilities increased from Dec. 2021 (¥569 Mil) to Dec. 2022 (¥727 Mil) but then declined from Dec. 2022 (¥727 Mil) to Dec. 2023 (¥547 Mil).

Huadong Medicine Co Other Long-Term Liabilities Historical Data

The historical data trend for Huadong Medicine Co's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Huadong Medicine Co Other Long-Term Liabilities Chart

Huadong Medicine Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Get a 7-Day Free Trial

Huadong Medicine Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Huadong Medicine Co Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Huadong Medicine Co Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Huadong Medicine Co's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Huadong Medicine Co (SZSE:000963) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Huadong Medicine Co Ltd (SZSE:000963) » Definitions » Other Long-Term Liabilities

Traded in Other Exchanges

N/A

Address

468 Yan’an Road, Floor 7, 9 and 10, Gate No. 1, Building No. 1, Hangzhou, CHN, 310006

Website

http://www.eastchinapharm.com

Huadong Medicine Co Ltd is engaged in the production and sales of antibiotics, proprietary Chinese medicine, chemical synthetic medicine and genetic engineering drugs products. It is also engaged in the wholesale, retail and distribution business of Chinese and western medicine, Chinese herbal medicine, medical apparatus, and instruments. The main business of the company is divided into pharmaceutical business sales and the industry of pharmaceutical. The product portfolio of the company includes Corbrin capsule, Cymusi, New Cyspin, Kasiping, Panlisu, Acarbose, and others.

Executives

He Ru Fen	Supervisors
Hu Bao Zhen	Supervisors
Zhou Shun Hua	Executives
Shao Ling Min	Supervisors
Wan Ling Ling	Executives
Fu Hang	Director
Yue Jin	Director
Chen Bo	Secretary Dong
Qin Yun	Supervisors
Li Bang Liang	Directors, executives
Zhou Jin Bao	Directors, executives

Huadong Medicine Co (SZSE:000963) Headlines

No Headlines